Your browser doesn't support javascript.
Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York (preprint)
medrxiv; 2020.
Preprint en Inglés | medRxiv | ID: ppzbmed-10.1101.2020.05.25.20113050
ABSTRACT
Importance New York State (NYS) is an epicenter of the United States' COVID-19 epidemic. Reliable estimates of cumulative incidence of SARS-CoV-2 infection in the population are critical to tracking the extent of transmission and informing policies, but US data are lacking, in part because societal closure complicates study conduct.

Objective:

To estimate the cumulative incidence of SARS-CoV-2 infection and percent of infections diagnosed in New York State, overall and by region, age, sex, and race and ethnicity.

Design:

Statewide cross-sectional seroprevalence study, conducted April 19-28, 2020.

Setting:

Grocery stores (n=99) located in 26 counties throughout NYS, which were essential businesses that remained open during a period of societal closure and attract a heterogenous clientele.

Participants:

Convenience sample of patrons >=18 years and residing in New York State, recruited consecutively upon entering stores and via an in-store flyer. Exposures Region (New York City, Westchester/Rockland, Long Island, Rest of New York State), age, sex, race and ethnicity. Main

Outcomes:

Primary

outcome:

cumulative incidence of SARS-CoV-2 infection, based on dry-blood spot (DBS) SARS-CoV-2 antibody reactivity; secondary

outcome:

percent of infections diagnosed.

Results:

Among 15,101 adults with suitable DBS specimens, 1,887 (12.5%) were reactive using a validated SARS-CoV-2 IgG microsphere immunoassay (sensitivity 87.9%, specificity 99.75%). Following post-stratification weighting on region, sex, age, and race and ethnicity and adjustment for assay characteristics, estimated cumulative incidence through March 29 was 14.0% (95% CI 13.3-14.7%), corresponding to 2,139,300 (95% CI 2,035,800-2,242,800) infection-experienced adults. Cumulative incidence was higher among Hispanic/Latino (29.2%, 95% CI 27.2-31.2%), non-Hispanic black/African American (20.2% 95% CI, 18.1-22.3%), and non-Hispanic Asian (12.4%, 95% CI 9.4-15.4%) adults than non-Hispanic white adults (8.1%, 95% CI 7.4-8.7%, p
Asunto(s)

Texto completo: Disponible Colección: Preprints Base de datos: medRxiv Asunto principal: COVID-19 Idioma: Inglés Año: 2020 Tipo del documento: Preprint

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Preprints Base de datos: medRxiv Asunto principal: COVID-19 Idioma: Inglés Año: 2020 Tipo del documento: Preprint